Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP
Condition(s):Erythropoietic ProtoporphyriaLast Updated:November 18, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Erythropoietic ProtoporphyriaLast Updated:November 18, 2023Active, not recruiting
Condition(s):Erythropoietic Protoporphyria; X-linked ProtoporphyriaLast Updated:March 15, 2024Recruiting
Condition(s):EPP; XLPLast Updated:March 13, 2024Active, not recruiting
Condition(s):Erythropoietic ProtoporphyriaLast Updated:November 19, 2020Completed
Condition(s):EPP; XLPLast Updated:May 15, 2023Completed
Condition(s):Erythropoietic ProtoporphyriaLast Updated:October 10, 2019Completed
Condition(s):Erythropoietic ProtoporphyriaLast Updated:October 2, 2018Completed
Condition(s):Erythropoietic Protoporphyria (EPP)Last Updated:February 28, 2024Completed
Condition(s):Erythropoietic Protoporphyria; EPP; X-linked Protoporphyria; XLPLast Updated:September 11, 2020Completed
Condition(s):Erythropoietic Protoporphyria; EPP; X-Linked Protoporphyria; XLP; XLPP; X-Linked Dominant Erythropoietic Protoporphyria; XLEPP; XLDPLast Updated:April 17, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.